Back The Guardian UK drug companies fined £260m for inflating prices for NHS
Search Sections 25 Jul
Close
Advertisement
Updated15 Jul 5:25am

UK drug companies fined £260m for inflating prices for NHS

The Guardian
Watchdog issues warning after abuses that included paying would-be rivals to stay out of the market The UK’s competition watchdog has imposed fines totalling more than £260m on pharmaceutical companies after an investigation found that they overcharged the NHS for hydrocortisone tablets for almost a decade. The Competition and Markets Authority (CMA) found that the drug’s makers Auden Mckenzie and Actavis UK, now known as Accord-UK, used their position as the sole providers of hydrocortisone to
Read full story
 Like Comment
Advertisement

Comments

No comments yet...
On the top

Date settings

Today is Sunday, July 25, 2021

+ 1 -
+ 1 -
+ 2016 -

Close

By using our website, you agree to the use of cookies as described in our cookie policy.

Accept

The Guardian

Close